ARDX
Ardelyx, Inc. · Healthcare
Chief Development Officer David P. Rosenbaum sold $242K of Ardelyx, Inc.
Sold$241,782
$5.97Price
40,507Shares
−6%Stake
What ARDX did after the filing
- The stock from Tue, Aug 20 close, $6.12
- +13.2%
- S&P 500, same days
- +2.1%
Measured over 30 trading days, to the Oct 2 close.
Traded Fri, Aug 16. Filed Tue, Aug 20, 2:59 PM ET, during the session. Returns use the Aug 20 close and the Oct 2 close. Not investment advice.